Colgate-Palmolive vs Procter & Gamble: Revenue, Profit and Business Model
Colgate-Palmolive had $20.4B of annual revenue in FY2025. Procter & Gamble had $87B of annual revenue in FY2026 and $16B of net income.
Latest financial snapshot
Colgate-Palmolive
- Latest annual revenue
- $20.4B (FY2025)
- Net income
- Unavailable here
- Net margin
- —
- Revenue growth
- +3.3% a year, FY2016–FY2025
Procter & Gamble
- Latest annual revenue
- $87B (FY2026)
- Net income
- $16B
- Net margin
- 18.4%
- Revenue growth
- +3.3% a year, FY2017–FY2026
Financial summary
Colgate-Palmolive
Colgate-Palmolive's revenue is steady rather than fast-growing. Net sales rose from $17.97 billion in 2022 to $20.10 billion in 2024 and $20.38 billion in 2025 (+1.4%, organic +1.4%). 2025 GAAP EPS fell 25% to $2.63 because of goodwill and intangible impairment charges tied to the skin health business (mainly Filorga), while Base Business EPS rose 3% to $3.69. Operating cash flow hit a record $4.2 billion and the company returned $2.9 billion through dividends and buybacks. In Q2 2026 net sales grew 4.9% to $5.361 billion, organic sales rose 2.4% and gross margin expanded 140 basis points to 61.5%. Colgate-Palmolive Company is a dominant multinational consumer products corporation, sustaining a market valuation typically over $70 billion.
Procter & Gamble
P&G's finances are defined by steady sales, high margins and large cash returns rather than fast growth. Net sales rose from $65.1 billion in fiscal 2017 to $87.0 billion in fiscal 2026. In fiscal 2026 diluted EPS was $6.62 (up 2%) and core EPS was $6.89 (up 1%), with core gross and operating margins slipping 40 and 70 basis points as costs rose. The company returned more than $15 billion to shareholders, about $10.2 billion in dividends and $5 billion in buybacks, and has raised its dividend for 70 consecutive years. For fiscal 2027 it guided to 1%-3% organic sales growth and core EPS of $6.89-$7.11. Procter & Gamble (P&G) is a dominant global consumer goods corporation, maintaining a formidable market valuation frequently exceeding $350 billion.
Revenue and profit by year
Colgate-Palmolive
| Year | Revenue | Net income | Margin | Growth | Source |
|---|---|---|---|---|---|
| FY2025 | $20.4B | — | — | +1.4% | Source |
| FY2024 | $20.1B | — | — | +3.3% | Source |
| FY2023 | $19.5B | — | — | +8.3% | Source |
| FY2022 | $18B | — | — | +3.1% | Source |
| FY2021 | $17.4B | $2.2B | 12.4% | +5.8% | Source |
| FY2020 | $16.5B | $2.7B | 16.4% | +5.0% | Source |
| FY2019 | $15.7B | $2.4B | 15.1% | +1.0% | Source |
| FY2018 | $15.5B | $2.4B | 15.4% | +0.6% | Source |
| FY2017 | $15.5B | $2B | 13.1% | +1.7% | Source |
| FY2016 | $15.2B | $2.4B | 16.1% | — | Source |
Procter & Gamble
| Year | Revenue | Net income | Margin | Growth | Source |
|---|---|---|---|---|---|
| FY2026 | $87B | $16B | 18.4% | +3.3% | Source |
| FY2025 | $84.3B | $16B | 19.0% | +0.3% | Source |
| FY2024 | $84B | $14.9B | 17.7% | +2.5% | Source |
| FY2023 | $82B | $14.7B | 17.9% | +2.3% | Source |
| FY2022 | $80.2B | $14.7B | 18.4% | +5.3% | Source |
| FY2021 | $76.1B | $14.3B | 18.8% | +7.3% | Source |
| FY2020 | $71B | $13B | 18.4% | +4.8% | Source |
| FY2019 | $67.7B | $3.9B | 5.8% | +1.3% | Source |
| FY2018 | $66.8B | $9.8B | 14.6% | +2.7% | Source |
| FY2017 | $65.1B | $15.3B | 23.6% | — | Source |
Where the revenue comes from
Colgate-Palmolive
- Oral Care
Largest category
Toothpaste, toothbrushes, mouthwash, whitening, and professional oral-care products under brands such as Colgate and elmex.
- Pet Nutrition
Major growth category
Hill's Science Diet and Hill's Prescription Diet pet food sold through retail and veterinary channels.
- Personal Care
Major category
Soap, body wash, deodorant, and personal-care brands including Palmolive, Softsoap, Irish Spring, and Sanex.
- Home Care
Smaller category
Dishwashing, household cleaning, and fabric-care products, with brand strength in select global markets.
Procter & Gamble
- Fabric and Home Care
Largest segment
Laundry, dish care, air care, and household cleaning brands including Tide, Ariel, Dawn, Febreze, and Swiffer.
- Baby, Feminine and Family Care
Major segment
Pampers, Always, Bounty, Charmin, and related baby, feminine, and family-care products.
- Beauty
Major segment
Hair care, skin care, and prestige beauty brands including Head & Shoulders, Pantene, Olay, and SK-II.
- Health Care
Major segment
Oral care and personal health products such as Oral-B, Crest, Vicks, and Metamucil.
- Grooming
Focused segment
Gillette, Venus, Braun, and shaving-related products.
Business model and strategy
Colgate-Palmolive
How it makes money
Colgate-Palmolive sells high-frequency, repeat-purchase consumer products. Revenue comes from four categories: Oral Care (Colgate, elmex, meridol, Tom's of Maine, hello), Personal Care (Palmolive, Softsoap, Irish Spring, Protex, Sanex, Speed Stick, EltaMD, PCA Skin, Filorga), Home Care (Ajax, Fabuloso, Palmolive dish liquid, Suavitel) and Pet Nutrition (Hill's Science Diet and Hill's Prescription Diet).
Growth strategy
Colgate-Palmolive's growth plan centers on premium oral care (whitening, sensitivity, gum health and electric brushes), expanding Hill's Science Diet and Prescription Diet, and selective skin health brands such as EltaMD and PCA Skin. Productivity savings fund higher advertising, and the company has exited low-margin private-label pet food to focus Hill's on its own brands.
Competitive advantage
Colgate-Palmolive's advantage is reach plus professional endorsement. Colgate toothpaste held 41.3% global share and manual toothbrushes 32.7% year to date in 2026, built on distribution that reaches small traditional-trade shops across India, Latin America and Africa.
Procter & Gamble
How it makes money
P&G makes money by designing, manufacturing and marketing branded household and personal-care products that consumers buy every week, then selling them through retailers, club stores, pharmacies, distributors and e-commerce platforms. Revenue comes from five reportable segments: Fabric & Home Care (Tide, Ariel, Dawn, Downy, Febreze), the largest; Baby, Feminine & Family Care (Pampers, Always, Bounty, Charmin);
Growth strategy
P&G's integrated growth strategy has five parts: a portfolio focused on about ten daily-use categories, superiority across product, packaging, communication, retail execution and value, productivity savings to fund reinvestment, 'constructive disruption' of its own practices, and an agile, accountable organization.
Competitive advantage
P&G's edge is the combination of category leadership and scale. It concentrates on about ten daily-use categories where performance differences are visible to consumers (cleaning, absorbency, shaving, oral care), funds roughly $2 billion a year of R&D to keep those gaps, and uses its size to buy materials, media and logistics more cheaply than smaller rivals.
Questions about Colgate-Palmolive vs Procter & Gamble
Which company has higher revenue — Colgate-Palmolive Company or The Procter & Gamble Company?
Colgate-Palmolive Company had $20.4B (FY2025), while The Procter & Gamble Company had $87.0B (FY2026). By latest annual revenue, The Procter & Gamble Company is the larger business, with Colgate-Palmolive Company showing a smaller revenue base. Note: these are from different fiscal years and are not a direct like-for-like comparison.
What is the market cap of Colgate-Palmolive Company vs The Procter & Gamble Company?
Colgate-Palmolive Company's market capitalisation stands at $69.0B, while The Procter & Gamble Company's is $340.0B. The Procter & Gamble Company carries the higher market valuation, reflecting investors' expectations of its future earnings power relative to Colgate-Palmolive Company.
How does revenue per employee compare for Colgate-Palmolive Company and The Procter & Gamble Company?
Colgate-Palmolive Company has $607k / employee in revenue per employee, while The Procter & Gamble Company has $798k / employee. Headcounts may use different dates, so the ratio alone does not establish which business operates more efficiently.
How do Colgate-Palmolive Company and The Procter & Gamble Company make money?
Colgate-Palmolive Company and The Procter & Gamble Company generate revenue in fundamentally different ways. Colgate-Palmolive Company: Colgate-Palmolive sells high-frequency, repeat-purchase consumer products. The Procter & Gamble Company: P&G makes money by designing, manufacturing and marketing branded household and personal-care products that consumers buy every week, then selling them through retailers, club stores, pharmacies, distributors and e-commerce platforms.
Which company is valued higher relative to revenue — Colgate-Palmolive Company or The Procter & Gamble Company?
On a price-to-sales (P/S) basis, Colgate-Palmolive Company trades at 3.4x P/S and The Procter & Gamble Company at 3.9x P/S. The Procter & Gamble Company commands a higher revenue multiple, typically indicating that investors expect faster growth or higher future margins compared to Colgate-Palmolive Company. A higher multiple is not inherently better — it may also signal that the stock is priced for perfection.
Is Colgate-Palmolive Company bigger than The Procter & Gamble Company?
By last reported revenue, The Procter & Gamble Company ($87.0B (FY2026)) is the larger company compared to Colgate-Palmolive Company ($20.4B (FY2025)). Revenue scale is one dimension of size — market capitalisation, employee count, and geographic reach are also relevant depending on the context.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Colgate-Palmolive vs Procter & Gamble overview